News

FDA ends recall of salmonella-contaminated brown eggs
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...
FDA approves 12-month flea treatment for dogs, marking veterinary breakthrough
FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.
FDA Publishes Full Texts of Response Letters to Drug Applications
By Stephanie Brown HealthDay ReporterTHURSDAY, July 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
Vending Machine Products Recall Map Shows States With New Warning
Sheehan Brothers Vending is recalling numerous products due to an undeclared sesame allergen missing from the products' ...
Senators hit funding snag over Trump FBI headquarters move
The Senate Appropriations Committee sputtered Thursday as its consideration of the annual Justice Department funding bill was ...
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
Moderna gets full US approval for COVID shot in at-risk children 6 months and older
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
FDA updates blood donation guidelines to try and increase number of donors
The U.S. Food and Drug Administration updated its blood donation guidelines. Now, it goes off individual risk assessment ...
Ritz Peanut Butter Cracker Sandwiches recalled for potential allergic reactions
A voluntary recall has been issued for select Ritz Peanut Butter Cracker Sandwiches that may be incorrectly labeled and cause ...
STAT3h
FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility
Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.
US FDA publishes 200 rejection letters in transparency push
The U.S. Food and Drug Administration on Thursday published more than 200 of its so-called complete response letters to drugmakers, a significant move to increase transparency of the agency's work.